Resources from the same session
63MO - Rechallenge of anlotinib in patients with advanced soft tissue sarcoma after progression on prior anlotinib treatment: A multicenter retrospective study
Presenter: Jing Chen
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
64MO - Eribulin (E) versus trabectedin (T) therapy in patients with advanced liposarcoma: Efficacy comparison using real-world data evidence from TriNetX platform
Presenter: Jesus Rodriguez Pascual
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
65MO - Clinicopathological risk score following neoadjuvant imatinib predicts relapse-free survival in patients with GIST
Presenter: Javier Pozas
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
Invited Discussant 63MO, 64MO and 65MO
Presenter: Armelle Dufresne
Session: Mini Oral session 1
Resources:
Slides
Webcast
Q&A and discussion
Session: Mini Oral session 1
Resources:
Webcast
66MO - Intravenous sirolimus (albumin bound, SRL-HSA) in malignant perivascular epithelioid cell tumors (PEComas): A multicenter, open label, phase Ib trial
Presenter: Xiaohui Niu
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
67MO - Long-term nirogacestat treatment in adult patients with desmoid tumors: Updated efficacy and safety from the phase III DeFi trial
Presenter: Bernd Kasper
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
Invited Discussant 66MO and 67MO
Presenter: Antonia Digklia
Session: Mini Oral session 1
Resources:
Slides
Webcast
Q&A and discussion
Session: Mini Oral session 1
Resources:
Webcast
60MO - Global trends in ongoing sarcoma clinical trials: Disparities and efficiencies
Presenter: Amalya Sargsyan
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast